{"url":"https://lda.senate.gov/api/v1/filings/3073d405-60fe-423d-b3a4-e0c4f3825bdd/","filing_uuid":"3073d405-60fe-423d-b3a4-e0c4f3825bdd","filing_type":"RR","filing_type_display":"Registration","filing_year":2014,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/3073d405-60fe-423d-b3a4-e0c4f3825bdd/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James W. Rock","dt_posted":"2014-07-10T19:00:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":33545,"url":"https://lda.senate.gov/api/v1/registrants/33545/","house_registrant_id":30422,"name":"ROCK & ASSOCIATES","description":"Government relations consultant.","address_1":"517 C Street, NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES W. ROCK","contact_telephone":"+1 703-627-8226","dt_updated":"2025-02-03T11:57:31.624210-05:00"},"client":{"id":141941,"url":"https://lda.senate.gov/api/v1/clients/141941/","client_id":152,"name":"TOWN & COUNTRY COMPOUNDING AND CONSULTING","general_description":"Compounding pharmacy.","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the operation of compounding pharmacies and the availability of compounded medications.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":"Staff Asst., US House Committee on Budget - 1985 to 2000","new":true}],"government_entities":[]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the operation of compounding pharmacies and the availability of compounded medications.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":"Staff Asst., US House Committee on Budget - 1985 to 2000","new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to the operation of compounding pharmacies and the availability of compounded medications.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":"Staff Asst., US House Committee on Budget - 1985 to 2000","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}